These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28729089)

  • 1. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A; de Souza RJ
    Parkinsonism Relat Disord; 2017 Oct; 43():120-121. PubMed ID: 28729089
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
    Růzicka E; Urgosík D; Jech R; Roth J; Vymazal J; Mecír P; Vladyka V
    Mov Disord; 2005 Jun; 20(6):759-62. PubMed ID: 15782419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
    Pita Lobo P; Coelho M; Mestre TA; Rosa MM; Ferreira JJ
    Mov Disord; 2013 Aug; 28(9):1212-4. PubMed ID: 23861327
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Ferrara JM; Adam OR; Ondo WG
    Arch Neurol; 2010 Jan; 67(1):114-5. PubMed ID: 20065139
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary.
    Fox S
    Mov Disord; 2013 Aug; 28(9):1214-5. PubMed ID: 23857852
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
    Perikal PJ; Jagannatha AT; Khanapure KS; Furtado SV; Joshi KC; Hegde AS
    World Neurosurg; 2018 Oct; 118():304-310. PubMed ID: 30055367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C; Silverdale MA; Varma A; Dick JP; Kellett MW
    Mov Disord; 2009 Dec; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract]   [Full Text] [Related]  

  • 8. On the coexistence of parkinsonism and tardive dyskinesia.
    Fann WE; Lake CR
    Dis Nerv Syst; 1974 Jul; 35(7):324-6. PubMed ID: 17894090
    [No Abstract]   [Full Text] [Related]  

  • 9. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.
    Zhang D; McGregor M; Bordia T; Perez XA; McIntosh JM; Decker MW; Quik M
    Mov Disord; 2015 Dec; 30(14):1901-1911. PubMed ID: 26573698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-Dopa-free learned dyskinetic behavior in a Parkinson's primate model.
    Li Q; Fernagut PO; Bezard E
    Mov Disord; 2019 Aug; 34(8):1237. PubMed ID: 31083822
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.
    Toft M; Dietrichs E
    Mov Disord; 2011 Oct; 26(12):2180-1. PubMed ID: 22021157
    [No Abstract]   [Full Text] [Related]  

  • 12. Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
    Han SC; Katus L; Frucht S
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():9. PubMed ID: 32775023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
    Sancesario G; Morrone LA; D'Angelo V; Castelli V; Ferrazzoli D; Sica F; Martorana A; Sorge R; Cavaliere F; Bernardi G; Giorgi M
    Neurochem Int; 2014 Dec; 79():44-56. PubMed ID: 25452081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of hemantane in injectable dosage form on levodopa-induced dyskinesia in rats with model parkinsonian syndrome].
    Kapitsa IG; Ivanova EA; Kokshenev II; Nepoklonov AV; Val'dman EA; Voronina TA
    Eksp Klin Farmakol; 2014; 77(5):3-5. PubMed ID: 25033563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?
    Konitsiotis S; Tsironis C
    Behav Brain Res; 2006 Jun; 170(2):337-41. PubMed ID: 16621050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
    Dulski J; Cerquera-Cleves C; Milanowski L; Kwiatek-Majkusiak J; Koziorowski D; Ross OA; Pentela-Nowicka J; Sławek J; Wszolek ZK
    Parkinsonism Relat Disord; 2022 Jul; 100():19-23. PubMed ID: 35691177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
    Sunwoo MK; Kim KM; Hong JY; Sohn YH; Lee PH
    Mov Disord; 2013 Jul; 28(8):1152-3. PubMed ID: 23386570
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
    Onofrj M; Bonanni L; Cossu G; Manca D; Stocchi F; Thomas A
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S233-6. PubMed ID: 20082998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test.
    Acharya M; Banerjee S; Chatterjee A; Mukherjee A; Biswas S; Gangopadhyay G; Biswas A
    Neurol India; 2021; 69(2):430-434. PubMed ID: 33904468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.